Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
- 1 July 1997
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 52 (1), 10-20
- https://doi.org/10.1038/ki.1997.298
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- The effect of a subnormal vitamin B-6 status on homocysteine metabolism.Journal of Clinical Investigation, 1996
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- HYPERHOMOCYSTEINEMIA IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS1Transplantation, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Plasma Homocysteine in the Acute and Convalescent Phases After StrokeStroke, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acidJournal of Internal Medicine, 1995
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Coronary risk prediction in adults (The Framingham Heart Study)The American Journal of Cardiology, 1987
- Red Cell and Plasma Amino Acid Concentrations in Renal FailureJournal of Parenteral and Enteral Nutrition, 1983